These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21695946)

  • 1. [Survival of probiotic microorganisms in the conditions in vitro imitating the process of human digestion].
    Darmov IV; Chicherin IIu; Pogorel'skiĭ IP; Lundovskikh IA
    Eksp Klin Gastroenterol; 2011; (3):6-11. PubMed ID: 21695946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative assessment of survival of probiotic microorganisms from commercial preparations under the conditions in vitro].
    Darmov IV; Chicherin IIu; Erdiakov AS; Pogorel'skiĭ IP; Lundovskikh IA
    Eksp Klin Gastroenterol; 2011; (9):96-101. PubMed ID: 22629784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacillus spp. with in vitro probiotic properties from human faeces and traditional fermented products.
    Vizoso Pinto MG; Franz CM; Schillinger U; Holzapfel WH
    Int J Food Microbiol; 2006 Jun; 109(3):205-14. PubMed ID: 16503361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession.
    Reuter G
    Curr Issues Intest Microbiol; 2001 Sep; 2(2):43-53. PubMed ID: 11721280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine.
    Maathuis AJ; Keller D; Farmer S
    Benef Microbes; 2010 Mar; 1(1):31-6. PubMed ID: 21831748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the passage of Lactobacillus gasseri K7 and bifidobacteria from the stomach to intestines using a single reactor model.
    Ritter P; Kohler C; von Ah U
    BMC Microbiol; 2009 May; 9():87. PubMed ID: 19426473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological activity of probiotic microorganisms].
    Novik GI; Samartsev AA; Astapovich NI; Kavrus MA; Mikhaliuk AN
    Prikl Biokhim Mikrobiol; 2006; 42(2):187-94. PubMed ID: 16761572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
    Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
    J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells.
    Wine E; Gareau MG; Johnson-Henry K; Sherman PM
    FEMS Microbiol Lett; 2009 Nov; 300(1):146-52. PubMed ID: 19765084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationships between the probiotic and host indigenous lactobacilli under the conditions of mixed cultivation in vitro].
    Glushanova NA; Shenderov BA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (2):56-61. PubMed ID: 15881941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dynamic model that simulates the human upper gastrointestinal tract for the study of probiotics.
    Mainville I; Arcand Y; Farnworth ER
    Int J Food Microbiol; 2005 Apr; 99(3):287-96. PubMed ID: 15808363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Joint cultivation of Bacillus subtilis and Escherichia coli strains promising for obtaining complex probiotic].
    Tsaruk'ianova IG; Osadchaia AI
    Mikrobiol Z; 2007; 69(2):43-9. PubMed ID: 17494334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients.
    Timmerman HM; Niers LE; Ridwan BU; Koning CJ; Mulder L; Akkermans LM; Rombouts FM; Rijkers GT
    Clin Nutr; 2007 Aug; 26(4):450-9. PubMed ID: 17544549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics.
    Grimoud J; Durand H; Courtin C; Monsan P; Ouarné F; Theodorou V; Roques C
    Anaerobe; 2010 Oct; 16(5):493-500. PubMed ID: 20670686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotic survival during a multi-layered tablet development as tested in a dynamic, computer-controlled in vitro model of the stomach and small intestine (TIM-1).
    Venema K; Verhoeven J; Verbruggen S; Espinosa L; Courau S
    Lett Appl Microbiol; 2019 Nov; 69(5):325-332. PubMed ID: 31454425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the antagonism between Lactobacillus, E. coli and Bac. Anthracoides].
    Intizarov MM
    Veterinariia; 1973 Feb; 49(2):41-2. PubMed ID: 4202005
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of survival of probiotic and non-probiotic lactic acid bacteria by yeasts in fermented milk under non-refrigerated conditions.
    Liu SQ; Tsao M
    Int J Food Microbiol; 2009 Sep; 135(1):34-8. PubMed ID: 19666198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro protocol for direct isolation of potential probiotic lactobacilli from raw bovine milk and traditional fermented milks.
    Baruzzi F; Poltronieri P; Quero GM; Morea M; Morelli L
    Appl Microbiol Biotechnol; 2011 Apr; 90(1):331-42. PubMed ID: 21318359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal colonisation, microbiota and future probiotics?
    Salminen S; Benno Y; de Vos W
    Asia Pac J Clin Nutr; 2006; 15(4):558-62. PubMed ID: 17077076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical models to optimize production of probiotic characteristics.
    Tomás MS; Bru E; Elena Nader-Macías M
    Methods Mol Biol; 2004; 268():355-65. PubMed ID: 15156046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.